Skip to main content

Table 1 List of the speakers, affiliations, titles of the talks and their corresponding section in the report

From: Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain

Speaker

Affiliation

Talk title

Section

Guido Kroemer

Institut Gustave Roussy, France.

Interferon, viral mimicry and chemotherapy. The hallmarks of immunogenicity.

Viral vectors and interferon-based approaches in cancer immunotherapy.

Cristian Smerdou

Center for Applied Medical Research (CIMA), Spain.

Alphavirus vectors for cancer immunotherapy.

Sandra Hervás-Stubbs

Center for Applied Medical Research (CIMA), Spain.

New roles for the Type I IFN system in cancer immunology.

David Escors

Navarrabiomed, Spain.

Ex vivo differentiation of cancer-specific myeloid-derived suppressor cells and their use in cancer immunotherapy.

David Sancho

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Spain.

A dendritic cell receptor for damaged self is crucial for anti-viral immunity.

Bettina Weigelin

Radboud University Nijmegen, The Netherlands.

Dynamic imaging reveals serial killing of cancer cells by CTL: New strategies to overcome tumor resistance niches.

Experimental tumor imaging in immunotherapy.

Philippe Bousso

Institut Pasteur, France.

In vivo imaging of immune tumor rejections.

Ignacio Melero

Center for Applied Medical Research (CIMA), Spain.

Making the most of CD137 and IL-15 for cancer immunotherapy.

Immunostimulatory monoclonal antibodies.

Bruno Paiva

Center for Applied Medical Research (CIMA), Spain.

Monitoring myeloma in minimal residual disease: a window of opportunity for immunotherapy.

Paolo Ascierto

National Tumor Institute Fondazione G. Pascale, Italy.

Biomarkers for check point blockade.

Kohrt Holbrook

Stanford University, USA.

Stimulation of Natural Killer Cells with an Anti-CD137 Antibody Enhances the Efficacy of Trastuzumab, Cetuximab & Rituximab.

Noelia Casares

Center for Applied Medical Research (CIMA), Spain.

Targeting FOXP3. Development of inhibitors for immune modulation.

Novel therapeutic agents for cancer immunotherapy.

Marisol Soengas

Spanish National Cancer Research Centre (CNIO), Spain.

New animal models for gene discovery and drug screening.

Fernando Pastor

Center for Applied Medical Research (CIMA), Spain.

CD137 and CD28 agonist aptamers.

Luis Álvarez-Vallina

Hospital Universitario Puerta de Hierro, Spain.

New antibody platforms in immunotherapy and anti-angiogenesis.